Blue Bell Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Blue Bell Private Wealth Management's BMY Position: Q2 2026 in Review

Blue Bell Private Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.25% in Q2 2026, buying an estimated $115 and bringing the position to 800 shares worth $46.1K. The position accounts for 0.01% of the portfolio, ranked #432.

Blue Bell Private Wealth Management first reported a position in BMY in Q4 2013 and has held it in 31 quarters since. The position peaked at $48.4K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Blue Bell Private Wealth Management held 800 shares of Bristol-Myers Squibb worth $46.1K as of Q2 2026.
• Blue Bell Private Wealth Management bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
• Bristol-Myers Squibb made up 0.01% of Blue Bell Private Wealth Management's portfolio in Q2 2026, its #432 holding.
• Blue Bell Private Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 31 quarters since.
• Blue Bell Private Wealth Management's Bristol-Myers Squibb position peaked at $48.4K in Q1 2026.
• 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.